Researchers have identified cell-free RNA signatures that can predict preterm birth over four months before delivery date. This discovery has the potential to revolutionize prevention strategies and save millions of lives worldwide, where 13.4 million newborns are delivered prematurely each year.
A phase 3 trial announced today demonstrated lorundrostat's safety and effectiveness in reducing blood pressure in patients with resistant hypertension. The treatment, which blocks the production of aldosterone from the adrenal glands, achieved clinically meaningful and sustained reductions in systolic blood pressure.
Researchers at HKUST developed a novel elastic alloy called Ti₇₈Nb₂₂, which achieves remarkable efficiency for solid-state heat pumping and exhibits a reversible temperature change 20 times greater than conventional metals. The alloy achieves approximately 90% of the Carnot efficiency limit, making it highly competitive with refrigeran...
Researchers explore how plants use ubiquitination to fend off pathogens, developing molecular tools for disease resistance. The team aims to design synthetic E3 ligases that can switch on immune pathways and target pathogen proteins, enhancing crop resilience.